![]() Specifically, the brief examines how the industry captures the regulatory apparatus and policymaking process via: We can’t ensure affordable life-saving drugs for all Americans until we fix that dynamic.” “This report illustrates just how much power drug companies exert over our policymakers, and really our democracy. “Most Americans intuitively understand that powerful companies are able to promote their interests in Washington, but we rarely get to see just how that influence-peddling affects our daily lives,” said Margetta Morgan. Written by Roosevelt Fellow Julie Margetta Morgan and Advocacy and Policy Associate Devin Duffy, the brief maps out how underhanded industry tactics, such as lobbying and skewed medical research, plague our health care system, endanger patients, and ultimately jeopardize our economy. Today, the Roosevelt Institute released the issue brief, “ The Cost of Capture: How the Pharmaceutical Industry has Corrupted Policy Makers and Harmed Patients,” which outlines how the pharmaceutical industry has skewed policymaking through corporate capture, a form of corruption in which industry-in prioritizing profits over patients-exerts undue influence over policymakers at the expense of public interest.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |